Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1729180

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1729180

Global Veterinary Glucose Monitoring Devices Market Size study, by Product (Glucose Meters, Consumables), Animal Type (Dogs, Cats), End-use, Distribution Channel, and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Veterinary Glucose Monitoring Devices Market is valued approximately at USD 0.71 billion in 2023 and is expected to expand at a promising CAGR of 7.60% during the forecast period 2024-2032. As pet ownership continues to surge globally, particularly in urban environments, the need for advanced, at-home, and in-clinic diagnostics for chronic conditions like diabetes in companion animals has grown markedly. Veterinary glucose monitoring devices are increasingly being integrated into daily veterinary practice and home-based care protocols for pets, notably dogs and cats, allowing for real-time glucose tracking, early intervention, and improved long-term disease management. These devices have evolved from rudimentary test strips to highly sensitive, species-specific digital meters and continuous glucose monitoring systems (CGMs) that provide invaluable insights into animal health.

Driving the growth of the market are rising incidences of diabetes mellitus in pets due to obesity and genetic predisposition, growing awareness among pet parents, and increasing veterinary expenditure globally. Moreover, innovations such as minimally invasive CGMs and Bluetooth-enabled devices compatible with smartphones have revolutionized animal diabetic care. As clinical veterinarians and pet owners alike prioritize disease prevention and chronic condition monitoring, glucose monitoring tools are no longer viewed as optional add-ons but as essential instruments for daily wellness checks and treatment compliance. This shift has significantly expanded the target demographic for such technologies beyond critical care and into routine health assessments.

The growth trajectory of veterinary glucose monitoring is also closely tied to the professionalization of veterinary services and diagnostics. The rise of corporate veterinary chains, the standardization of diagnostic protocols, and the introduction of pet insurance that reimburses chronic condition management have all contributed to demand. Furthermore, distribution networks have become increasingly streamlined, with online veterinary pharmacies, e-commerce platforms, and mobile vet services accelerating the accessibility of these monitoring tools even in remote or underserved areas. Manufacturers are now also investing in developing breed-specific calibrations and pediatric-compatible glucose sensors to meet diverse end-user needs more precisely.

Regionally, North America leads the global veterinary glucose monitoring devices market, fueled by high pet ownership rates, favorable reimbursement policies, and a robust ecosystem of veterinary clinics and pet diagnostic labs. Europe closely follows, supported by proactive pet health regulations and technological innovation in animal healthcare products. Meanwhile, Asia Pacific is anticipated to witness the fastest growth during the forecast timeline, driven by increasing pet adoption, awareness campaigns on animal wellness, and a booming veterinary services sector in countries such as India, China, and Japan. Latin America and the Middle East & Africa, while comparatively nascent, are gaining traction through strategic collaborations and growing urban pet care infrastructure.

Major market player included in this report are:

  • Zoetis Inc.
  • IDEXX Laboratories, Inc.
  • Elanco Animal Health
  • Nova Biomedical
  • Merck Animal Health
  • UBI Group
  • PetTest
  • Woodley Equipment Company
  • Virbac
  • Bionet America Inc.
  • BioNote Inc.
  • TaiDoc Technology Corporation
  • Trividia Health, Inc.
  • Medtronic Plc
  • Alphatrak

The detailed segments and sub-segment of the market are explained below:

By Product

  • Glucose Meters
  • Consumables

By Animal Type

  • Dogs
  • Cats

By End-use

  • Veterinary Hospitals & Clinics
  • Homecare Settings
  • Research & Academic Institutes

By Distribution Channel

  • Retail Pharmacies
  • Online Pharmacies
  • Veterinary Clinics

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of MEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Veterinary Glucose Monitoring Devices Market Executive Summary

  • 1.1. Global Veterinary Glucose Monitoring Devices Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product
    • 1.3.2. By Animal Type
    • 1.3.3. By End-use
    • 1.3.4. By Distribution Channel
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Veterinary Glucose Monitoring Devices Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Buyer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Veterinary Glucose Monitoring Devices Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Incidence of Diabetes in Companion Animals
    • 3.1.2. Technological Innovation in Continuous Monitoring Systems
    • 3.1.3. Increasing Pet Owner Awareness and Insurance Coverage
  • 3.2. Market Challenges
    • 3.2.1. High Cost of Advanced Monitoring Devices
    • 3.2.2. Regulatory Hurdles for Species-Specific Calibration
  • 3.3. Market Opportunities
    • 3.3.1. Integration with Tele-veterinary Platforms
    • 3.3.2. Expansion in Emerging Markets
    • 3.3.3. Development of Wearable and Implantable Sensors

Chapter 4. Global Veterinary Glucose Monitoring Devices Market Industry Analysis

  • 4.1. Porter's Five Forces Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's Model
    • 4.1.7. Porter's Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspectives
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Veterinary Glucose Monitoring Devices Market Size & Forecasts by Product 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Glucose Meters
    • 5.2.2. Consumables

Chapter 6. Global Veterinary Glucose Monitoring Devices Market Size & Forecasts by Animal Type 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Market: Animal Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Dogs
    • 6.2.2. Cats

Chapter 7. Global Veterinary Glucose Monitoring Devices Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Market
    • 7.1.1. U.S. Market
      • 7.1.1.1. Segment breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Market
  • 7.2. Europe Market
    • 7.2.1. UK Market
    • 7.2.2. Germany Market
    • 7.2.3. France Market
    • 7.2.4. Spain Market
    • 7.2.5. Italy Market
    • 7.2.6. Rest of Europe Market
  • 7.3. Asia Pacific Market
    • 7.3.1. China Market
    • 7.3.2. India Market
    • 7.3.3. Japan Market
    • 7.3.4. Australia Market
    • 7.3.5. South Korea Market
    • 7.3.6. Rest of Asia Pacific Market
  • 7.4. Latin America Market
    • 7.4.1. Brazil Market
    • 7.4.2. Mexico Market
  • 7.5. Middle East & Africa Market
    • 7.5.1. Saudi Arabia Market
    • 7.5.2. South Africa Market
    • 7.5.3. Rest of MEA Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Zoetis Inc.
    • 8.1.2. IDEXX Laboratories, Inc.
    • 8.1.3. Elanco Animal Health
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Zoetis Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. IDEXX Laboratories, Inc.
    • 8.3.3. Elanco Animal Health
    • 8.3.4. Nova Biomedical
    • 8.3.5. Merck Animal Health
    • 8.3.6. UBI Group
    • 8.3.7. PetTest
    • 8.3.8. Woodley Equipment Company
    • 8.3.9. Virbac
    • 8.3.10. Bionet America Inc.
    • 8.3.11. BioNote Inc.
    • 8.3.12. TaiDoc Technology Corporation
    • 8.3.13. Trividia Health, Inc.
    • 8.3.14. Medtronic Plc
    • 8.3.15. Alphatrak

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!